India reports highest one-day spike of 97,570 COVID-19 cases, tally crosses 46 lakh mark

India has reported an unprecedented surge in number of COVID-19 infections being reported on a daily basis. On September 12, country yet again reported its highest single-day spike of 97,750 cases taking tally to over 46 lakhs, while 1,201 people succumbed to virus, taking death toll to 77,472.

Union Health Ministry has taken to Twitter to explain COVID-19 situation in country. Health Ministry posted a graph which depicted percent of COVID-19 recoveries has been improving on a regular basis as against percent of active cases in country.

RE | Coronavirus LIVE Updates: India's Tally At 46,59,985; DCGI Sends tice To Serum Institute

RE | COVID Numbers Explained: Centre Cites Aggressive Testing & Reducing Mortality As Key Wins

Mortality rate decreased

COVID-19 infections in country are being detected due to Centre's strategy of aggressive testing, after which, due treatment is being given to infected patients, in turn, improving recovery rate. Health Ministry has apprised that India's mortality rate is one of lowest in world.  

Currently, mortality rate stands at merely 1.67 per cent as compared to previously 2.15 per cent in first week of August and  recovery rate is also improving massively with mortality rate getting lower by day. According to Ministry, India's COVID-19 deaths per million population is 53 which is among lowest across world.

Ministry h apprised that five states - Maharashtra, Andhra Presh, Karnataka, Tamil Nu and Uttar Presh have approximately 62 per cent of total COVID-19 cases in India and also account for 70 per cent of all COVID-19 deaths in country. According to Ministry, India's COVID-19 deaths per million population is 53 which is among lowest across world.

total number of COVID-19 infections in country has risen to 46,59,984, of which 9,58,316 are active cases, while 36,24,196 have recovered from infection and 77,472 have succumbed to virus. About 10,91,251 samples were tested on Friday, taking count of total COVID-19 tests to over 5.5 crores. country is conducting more than 11 lakh tests on an aver on a daily basis.

India's race to COVID-19 vaccine

India has three vaccine candidates in race to develop a potential vaccine for dely virus. Hyderab based Bharat Biotech's vaccine candidate Covaxin is in phase II of human trials. Bharat Biotech on Friday anunced that its trials on animals were successful and has shown efficacy on virus. second candidate is Ahmedab based Zydus Cila's ZyCoV-D whereas  third one is being developed by Serum Institute of India in collaboration with Oxford University vaccine and UK's Pharmaceutical giant AstraZeneca. However,  Serum Institute has halted trials for its vaccine Covishield after a show-cause tice by Drugs Controller General of India.

(Im credits: PTI)

RE | 'Animal Trials Of COVID-19 Vaccine Candidate Covaxin Successful': Bharat Biotech

RE | India Votes In Favour Of UNGA Resolution, Calling For Multilateral Cooperation To Combat COVID